Incyte | INCY - 普通股股本



金融业
股票价格
USD
资产
USD 7.87B
现金及等价物
USD 3.98B
销售成本
USD 104.96M
流动资产
USD 6.03B
流动负债
USD 1.31B
债务
USD 38.27M
EBIT
USD 700.4M
EBITDA
USD 778.57M
员工
2.62K
EPS每股收益
USD 3.09
股本和储备
USD 6.34B
销售毛利
USD 1.57B
债务利息支出
USD 582K
利息收入
USD 38.12M
贷款资金
USD 28.42M
市值
USD 27.47B
净收入
USD 585.61M
营业费用
USD 973.64M
营业利润
USD 700.4M
普通股股本
USD 200.98M
PE价格收益
14.45
税前利润
USD 751.51M
销售收入
USD 1.67B
销售和管理费用
USD 351.74M
股票
USD 112.54M
贸易债权人
USD 1.39B
应收帐款人
USD 1.13B


普通股股本 更改 日
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Agenus USD 38.52M 3.2M 2026-03
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amgen USD 541M 1000K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
MacroGenics USD 63.56M 241K 2026-03
Merck USD 2.47B 4.93M 2026-03
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Neurocrine Biosciences USD 100.55M 50K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 0 2026-06
PTC Therapeutics USD 82.88M 1.41M 2026-03
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sarepta Therapeutics USD 105.62M 53K 2026-06
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Vertex Pharmaceuticals USD 253.3M 900K 2026-06